Last Updated : August 5, 2025
Details
| Call for patient/clinician input open | August 14, 2024 |
|---|---|
| Call for patient/clinician input closed | October 07, 2024 |
| Submission received | October 02, 2024 |
| Submission accepted | October 17, 2024 |
| Review initiated | October 18, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | January 09, 2025 |
| Deadline for sponsors comments | January 20, 2025 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | February 13, 2025 |
| Expert committee meeting (initial) | February 26, 2025 |
| Draft recommendation issued to sponsor | March 18, 2025 |
| Draft recommendation posted for stakeholder feedback | March 27, 2025 |
| End of feedback period | April 10, 2025 |
| Clarification: - Reconsideration: major and minor revisions requested by sponsor | |
| Expert committee meeting | June 25, 2025 |
| Final recommendation issued to sponsor and drug plans | July 10, 2025 |
| Final recommendation posted | July 28, 2025 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | July 24, 2025 |
| CDA-AMC review report(s) posted | - |